Name | MMAE |
---|---|
Supplier | Tocris Bioscience |
Catalog | 4104 |
Prices | $129.00 |
Sizes | 1 mg |
Cas Number | 474645-27-7 |
Chemical Name | N-Methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide |
Formula | C39H67N5O7 |
Molecular Weight | 717.98 |
Purity | >98 % |
Description | Potent, synthetic, cytotoxic analog of dolastatin 10 (Cat. No. 3375). Suppresses tumor cell viability in vitro (GIC 50 values are 0.22, 0.49 and 0.54 nM in BT474, MDA-MB-361-DYT2 and N87 cells, respectively). MMAE derivatives have been shown to induce regression of established tumor xenografts when conjugated to tumor targeting antibodies via a protease-cleavable linker. |
Supplier Page | Shop |
Rao KS, Mishra SH. J Ethnopharmacol. 1998 Apr;60(3):207-13.
Tang H, Lu JY, Zheng X, Yang Y, Reagan JD. Biochem Biophys Res Commun. 2008 Oct 31;375(4):562-5. doi:
Hanson J, Gille A, Zwykiel S, Lukasova M, Clausen BE, Ahmed K, Tunaru S, Wirth A, Offermanns S. J Clin Invest. 2010 Aug;120(8):2910-9.
Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M, Rhodes KJ. J Pharmacol Exp Ther. 2012 Apr;341(1):274-84.